-
2024-514156-33-00
5
2019-08-20
Patients in remission for granulomatosis with polyangiitis (GPA,
Wegen
-
2024-511862-35-00
4
2019-07-19
Adults with non-contrast-enhancing diffuse brainstem gliomas with non-
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2024-518578-15-00
5
2018-02-05
Is to demonstrate a non inferior efficacy of azithromycin and so the p
-
2024-516103-16-00
4
2015-12-04
Acute Lymphoblastic Leukemia (ALL) in younger adults (18-59 years)
-
2023-508235-31-00
5
2024-06-17
Atopic Dermatitis
-
2023-505972-32-00
5
2024-02-26
locally advanced anal squamous cell carcinoma
-
2022-501372-25-00
4
2024-01-10
Patients aged 18 years and older with relapsed or refractory FLT3 muta
-
2022-502578-18-00
11
2023-11-07
Rheumatoid Arthritis
-
2023-503652-27-00
5
2023-10-06
Melanoma
-
2022-501576-25-00
5
2023-07-07
Melanoma
-
2022-502103-30-00
4
2023-04-25
advanced non-squamous non-small cell lung cancer
-
2022-501217-31-00
10
2023-03-09
Hepatocellular carcinoma
-
2022-500419-38-00
5
2022-12-28
vasoplegic syndrome
-
2023-510097-14-00
5
2022-04-15
Patients with MMR deficient relapse or advanced / metastatic endometri
-
2023-507342-84-00
5
2021-10-26
Bladder Cancer
-
2023-503591-25-00
5
2020-06-09
Non-small cell lung cancer
-
2023-503500-87-00
11
2020-03-17
Muscle Invasive Bladder Cancer
-
2022-501531-16-00
5
2020-01-24
esophageal carcinoma
-
2022-502478-18-00
4
2019-12-20
Acute Myeloid Leukemia (AML)
-
2024-514885-38-00
5
2019-07-11
severe forms of mucous membrane pemphigoid
-
2024-513728-40-00
5
2019-07-02
scheduled surgery for digestive cancer
-
2023-510357-42-00
5
2019-05-22
hormone receptor (HR)-positive, HER2-negative,
early breast cancer (EB
-
2022-500451-23-00
5
2019-03-18
Adults with a de novo glioblastoma